However, these PVs do not interfere with the tumour suppressor functions of SMARCB1. Thus, the CSS-causing SMARCB1 PVs may specifically affect central nervous system development but do not cause malignancy in patients with CSS. The gene discussed is SMARCB1; the disease is neoplasm.